CellBion Co., Ltd. (KOSDAQ:308430)
30,500
-1,100 (-3.48%)
At close: Apr 9, 2026
CellBion Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,965 | 1,209 | 870.41 | 1,236 | 807.12 |
Short-Term Investments | 21,943 | 29,250 | 6,500 | 4,177 | 9,940 |
Cash & Short-Term Investments | 23,908 | 30,459 | 7,370 | 5,412 | 10,747 |
Cash Growth | -21.51% | 313.26% | 36.18% | -49.64% | 149.14% |
Accounts Receivable | 195.22 | 245.87 | 370.23 | 195.86 | 11.8 |
Other Receivables | 234.16 | 225.49 | 46.96 | 41.1 | 15.58 |
Receivables | 429.39 | 471.36 | 417.19 | 236.96 | 27.37 |
Inventory | 358.84 | 483.63 | 505.71 | 680.24 | 362.1 |
Prepaid Expenses | 253.58 | 131.06 | 50.74 | 94.44 | 63.46 |
Other Current Assets | 153.67 | 25.68 | 656.97 | 1,139 | 453.55 |
Total Current Assets | 25,103 | 31,571 | 9,001 | 7,563 | 11,654 |
Property, Plant & Equipment | 8,856 | 955.78 | 1,420 | 1,603 | 1,366 |
Long-Term Investments | - | 1,000 | 235.66 | 224.95 | 218.45 |
Other Intangible Assets | 761.24 | 634.8 | 688.93 | 645.92 | 613.07 |
Other Long-Term Assets | 473.96 | 246.26 | - | - | - |
Total Assets | 35,195 | 34,408 | 11,346 | 10,037 | 13,851 |
Accounts Payable | 178.04 | 41.13 | 6.08 | 201.65 | 29.43 |
Accrued Expenses | 725.79 | 489.11 | 211.63 | 276.15 | 246.93 |
Short-Term Debt | 254 | 254 | 254 | 254 | 285 |
Current Portion of Long-Term Debt | 200.01 | - | 295.27 | 1,407 | 1,116 |
Current Portion of Leases | 638.48 | 198 | 409.02 | 377.65 | 317.81 |
Current Unearned Revenue | - | - | 39.23 | 30.2 | 18 |
Other Current Liabilities | 265.3 | 85.13 | 322.24 | 2,730 | 1,622 |
Total Current Liabilities | 2,262 | 1,067 | 1,537 | 5,277 | 3,635 |
Long-Term Debt | 999.99 | 1,200 | - | - | - |
Long-Term Leases | 6,327 | 402.42 | 577.46 | 739.17 | 584.92 |
Long-Term Unearned Revenue | - | - | 625.72 | 443.91 | 433.11 |
Pension & Post-Retirement Benefits | 1,777 | 1,453 | 1,107 | 838.49 | 725.91 |
Other Long-Term Liabilities | 1,042 | 709.98 | - | - | - |
Total Liabilities | 12,408 | 4,833 | 3,848 | 7,299 | 5,378 |
Common Stock | 6,416 | 6,401 | 5,385 | 4,853 | 4,851 |
Additional Paid-In Capital | 65,821 | 65,422 | 37,368 | 29,483 | 29,461 |
Retained Earnings | -51,176 | -43,570 | -36,185 | -32,511 | -26,219 |
Comprehensive Income & Other | 1,726 | 1,322 | 929.73 | 913.21 | 379.03 |
Shareholders' Equity | 22,787 | 29,575 | 7,497 | 2,738 | 8,472 |
Total Liabilities & Equity | 35,195 | 34,408 | 11,346 | 10,037 | 13,851 |
Total Debt | 8,420 | 2,054 | 1,536 | 2,778 | 2,303 |
Net Cash (Debt) | 15,488 | 28,405 | 5,835 | 2,634 | 8,444 |
Net Cash Growth | -45.48% | 386.83% | 121.48% | -68.80% | 258.02% |
Net Cash Per Share | - | 2798.15 | 588.21 | 271.47 | 960.27 |
Filing Date Shares Outstanding | - | 12.8 | 10.77 | 9.71 | 9.7 |
Total Common Shares Outstanding | - | 12.8 | 10.77 | 9.71 | 9.7 |
Working Capital | 22,841 | 30,504 | 7,464 | 2,286 | 8,019 |
Book Value Per Share | - | 2310.37 | 696.10 | 282.15 | 873.28 |
Tangible Book Value | 22,025 | 28,940 | 6,809 | 2,093 | 7,859 |
Tangible Book Value Per Share | - | 2260.78 | 632.14 | 215.60 | 810.08 |
Machinery | 4,349 | 3,899 | 4,496 | 4,427 | 4,022 |
Construction In Progress | 731 | - | 19.26 | 51.74 | - |
Leasehold Improvements | - | - | 32.5 | 44.5 | 44.5 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.